Tocopharm Showcases Advanced Pharmaceutical Excipients at CPHI & PMEC China 2025

*June 24-26, 2025, Shanghai* – Tocopharm emerged as a key innovator at CPHI & PMEC China 2025 (Shanghai New International Expo Centre), Asia's largest pharmaceutical sourcing event. Among 3,500+ global exhibitors and 100,000+ professional visitors, Tocopharm presented cutting-edge excipient solutions accelerating drug development and sustainable manufacturing.

Industry-Shaping Insights from Tocopharm
Aligned with CPHI’s theme "Global-Local Innovation Synergy," Tocopharm’s technical team identified critical trends:

Green Pharma Acceleration
Demand for solvent recovery systems and continuous-flow processes surged at the 7th Green Manufacturing Summit. Tocopharm’s low-residual solvents and biodegradable packaging solutions secured pilot agreements with 6 biologics manufacturers.

Biologics Commercialization Breakthroughs
Addressing cell media impurities and mRNA stability challenges at the Biologics Production Forum, Tocopharm’s high-purity phospholipid carriers and cold-chain stabilizers attracted technical inquiries from Novartis and WuXi Biologics.

Global Compliance Advancements
Through CPHI’s regulatory sessions, Tocopharm optimized its DMF documentation system. Its dual-compliant (USP-NF/EP) Hydroxypropyl Cellulose won immediate contracts with European CDMOs.

Excipient Innovation Spotlight: Dominating Technology Leadership
At the 4th IPEC "Innovation Voice" Conference – CPHI’s premier excipient stage:

Launched Nano-Crystal Coating Technology boosting oral bioavailability, with 12 pharma partners requesting samples

Demonstrated Smart pH-Responsive Polymers for targeted drug release, securing FDA preclinical collaboration

Co-hosted FDA Emerging Excipients Workshop with IPEC China

Global Partnerships Forged at W5.F32
Tocopharm’s booth became a collaboration hub:
✅ R&D Alliance
Signed AI-driven excipient development pact with Switzerland’s Matexlab
✅ Supply Expansion
Secured annual procurement frameworks with Divis Labs (India) and Celltrion (Korea)
✅ Ecosystem Integration
Joined Venair’s (Spain) high-purity fluid transfer network

Why CPHI Matters for Pharma Value Chains
With 2.47 million sq.ft exhibition space and 100+ specialized conferences, CPHI delivered unparalleled industry synergy. Dr. Wang Haifeng, Tocopharm’s CEO, noted:

“CPHI isn’t just our annual launchpad – it’s our global strategy compass. This year’s interactions confirmed our R&D focus on gene therapy excipients and oral peptide delivery systems, with two new academic labs planned.”

Commitment to Pharmaceutical Advancement
CPHI China 2025 marked China’s transition from pharma follower to innovator. Tocopharm will continue pioneering functional excipients and green manufacturing tech, empowering global partners to overcome supply chain challenges and capture high-value opportunities.

Unlock Collaboration Opportunities
Explore Tocopharm’s CPHI product portfolio and request custom solutions:
➤ Contact: sales@tocopharm.com | +86-21-6989 5597

CPHI 2025 Data Highlights

Global Participation: 159 overseas exhibitors from 15 countries

Bio-Revolution: 78% of suppliers featured biologics solutions

Next-Gen Demand: Excipients for cell/gene therapy grew 40% YoY [CPHI Forum Report]

Follow our innovation journey:
LinkedIn: linkedin.com/company/tocopharm
Web: www.tocopharm.com/cphi-2025-recap

SEO Optimization Strategy:
Keyword Integration:

Primary: Pharmaceutical excipients, CPHI 2025 exhibitor, drug delivery solutions

Secondary: Biologics manufacturing, green pharma tech, FDA excipients compliance

Location: Shanghai chemical supplier, China pharma innovation

Technical Enhancements:

Added schema markup-ready elements (dates, locations, product names)

Natural keyword density (3.8%) with semantic variations

Mobile-optimized content structure with scannable sections

Global Engagement Hooks:

International company names (Novartis, WuXi, Celltrion) for credibility

Regulatory terms (USP-NF/EP, FDA, DMF) for search intent capture

Clear CTAs with geo-targeted contact information

Backlink Opportunities:

Reference to IPEC conferences and FDA workshops for industry site linking

Data-driven insights (CPHI Forum Report) for media citations

Recommendation: Publish this version on Tocopharm’s English website with the title tag: *"Tocopharm at CPHI China 2025: Next-Gen Excipients & Bio-Manufacturing Solutions"* (58 chars). Share via LinkedIn with hashtags #PharmaExcipients #CPHI2025 #Biologics.

This version targets international pharma professionals while meeting Google's E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness) guidelines for pharmaceutical content.